Diagnostic accuracy of cardiac MRI, FDG-PET, and myocardial biopsy for the diagnosis of cardiac sarcoidosis: a protocol for a systematic review and meta-analysis

Background:CS constitutes a rare but potentially underdiagnosed and fatal disease. Its diagnosis remains difficult owing to the infrequent and indistinguishable symptoms and the lack of formal diagnostic criteria dependent upon the diagnostic techniques used. Early diagnosis and treatment, however,...

Cur síos iomlán

Sonraí bibleagrafaíochta
Príomhchruthaitheoirí: Roth, D, Kadoglou, N, Leeflang, M, Spijker, R, Herkner, H, Trivella, M
Formáid: Journal article
Teanga:English
Foilsithe / Cruthaithe: BioMed Central 2020
_version_ 1826285023922225152
author Roth, D
Kadoglou, N
Leeflang, M
Spijker, R
Herkner, H
Trivella, M
author_facet Roth, D
Kadoglou, N
Leeflang, M
Spijker, R
Herkner, H
Trivella, M
author_sort Roth, D
collection OXFORD
description Background:CS constitutes a rare but potentially underdiagnosed and fatal disease. Its diagnosis remains difficult owing to the infrequent and indistinguishable symptoms and the lack of formal diagnostic criteria dependent upon the diagnostic techniques used. Early diagnosis and treatment, however, may help to counter its poor prognosis.We aim to characterize and compare the diagnostic accuracy of cardiac MRI, FDG-PET and myocardial biopsy for the diagnosis of cardiac sarcoidosis and to advance and compare methods for complex diagnostic test accuracy reviews and meta-analysis. Methods:Following a systematic review on DTA studies on the aforementioned topic, a four-part approach to meta-analysis will be used: (1) direct comparison of index tests with clinical reference standard, (2) indirect comparison of index tests with clinical reference standard, (3) addition of an alternative test to that indirect comparison (4) and Bayesian meta-analysis using results of part 3 as informative prior for comparisons analogous to part 1 and 2. Discussion:The most widely recognized diagnostic algorithm for cardiac sarcoidosis is considered out of date, as it precedes the introduction of imaging techniques in diagnostic pathways. These novel imaging techniques, like CMR and FDG-PET scan, have emerged as promising diagnostic tools which may fill the current diagnostic gap. Thus, a systematic review and evaluation of CS diagnosis are much needed. Such an attempt is anticipated to alter the current diagnostic guidelines for CS by shedding more light on the role of sophisticated imaging techniques on prompt CS therapy and follow-up. Trial registration:PROSPERO, CRD42019047126.
first_indexed 2024-03-07T01:22:39Z
format Journal article
id oxford-uuid:90e25569-dbd5-492f-a50a-3520ec872597
institution University of Oxford
language English
last_indexed 2024-03-07T01:22:39Z
publishDate 2020
publisher BioMed Central
record_format dspace
spelling oxford-uuid:90e25569-dbd5-492f-a50a-3520ec8725972022-03-26T23:14:50ZDiagnostic accuracy of cardiac MRI, FDG-PET, and myocardial biopsy for the diagnosis of cardiac sarcoidosis: a protocol for a systematic review and meta-analysisJournal articlehttp://purl.org/coar/resource_type/c_dcae04bcuuid:90e25569-dbd5-492f-a50a-3520ec872597EnglishSymplectic ElementsBioMed Central 2020Roth, DKadoglou, NLeeflang, MSpijker, RHerkner, HTrivella, MBackground:CS constitutes a rare but potentially underdiagnosed and fatal disease. Its diagnosis remains difficult owing to the infrequent and indistinguishable symptoms and the lack of formal diagnostic criteria dependent upon the diagnostic techniques used. Early diagnosis and treatment, however, may help to counter its poor prognosis.We aim to characterize and compare the diagnostic accuracy of cardiac MRI, FDG-PET and myocardial biopsy for the diagnosis of cardiac sarcoidosis and to advance and compare methods for complex diagnostic test accuracy reviews and meta-analysis. Methods:Following a systematic review on DTA studies on the aforementioned topic, a four-part approach to meta-analysis will be used: (1) direct comparison of index tests with clinical reference standard, (2) indirect comparison of index tests with clinical reference standard, (3) addition of an alternative test to that indirect comparison (4) and Bayesian meta-analysis using results of part 3 as informative prior for comparisons analogous to part 1 and 2. Discussion:The most widely recognized diagnostic algorithm for cardiac sarcoidosis is considered out of date, as it precedes the introduction of imaging techniques in diagnostic pathways. These novel imaging techniques, like CMR and FDG-PET scan, have emerged as promising diagnostic tools which may fill the current diagnostic gap. Thus, a systematic review and evaluation of CS diagnosis are much needed. Such an attempt is anticipated to alter the current diagnostic guidelines for CS by shedding more light on the role of sophisticated imaging techniques on prompt CS therapy and follow-up. Trial registration:PROSPERO, CRD42019047126.
spellingShingle Roth, D
Kadoglou, N
Leeflang, M
Spijker, R
Herkner, H
Trivella, M
Diagnostic accuracy of cardiac MRI, FDG-PET, and myocardial biopsy for the diagnosis of cardiac sarcoidosis: a protocol for a systematic review and meta-analysis
title Diagnostic accuracy of cardiac MRI, FDG-PET, and myocardial biopsy for the diagnosis of cardiac sarcoidosis: a protocol for a systematic review and meta-analysis
title_full Diagnostic accuracy of cardiac MRI, FDG-PET, and myocardial biopsy for the diagnosis of cardiac sarcoidosis: a protocol for a systematic review and meta-analysis
title_fullStr Diagnostic accuracy of cardiac MRI, FDG-PET, and myocardial biopsy for the diagnosis of cardiac sarcoidosis: a protocol for a systematic review and meta-analysis
title_full_unstemmed Diagnostic accuracy of cardiac MRI, FDG-PET, and myocardial biopsy for the diagnosis of cardiac sarcoidosis: a protocol for a systematic review and meta-analysis
title_short Diagnostic accuracy of cardiac MRI, FDG-PET, and myocardial biopsy for the diagnosis of cardiac sarcoidosis: a protocol for a systematic review and meta-analysis
title_sort diagnostic accuracy of cardiac mri fdg pet and myocardial biopsy for the diagnosis of cardiac sarcoidosis a protocol for a systematic review and meta analysis
work_keys_str_mv AT rothd diagnosticaccuracyofcardiacmrifdgpetandmyocardialbiopsyforthediagnosisofcardiacsarcoidosisaprotocolforasystematicreviewandmetaanalysis
AT kadogloun diagnosticaccuracyofcardiacmrifdgpetandmyocardialbiopsyforthediagnosisofcardiacsarcoidosisaprotocolforasystematicreviewandmetaanalysis
AT leeflangm diagnosticaccuracyofcardiacmrifdgpetandmyocardialbiopsyforthediagnosisofcardiacsarcoidosisaprotocolforasystematicreviewandmetaanalysis
AT spijkerr diagnosticaccuracyofcardiacmrifdgpetandmyocardialbiopsyforthediagnosisofcardiacsarcoidosisaprotocolforasystematicreviewandmetaanalysis
AT herknerh diagnosticaccuracyofcardiacmrifdgpetandmyocardialbiopsyforthediagnosisofcardiacsarcoidosisaprotocolforasystematicreviewandmetaanalysis
AT trivellam diagnosticaccuracyofcardiacmrifdgpetandmyocardialbiopsyforthediagnosisofcardiacsarcoidosisaprotocolforasystematicreviewandmetaanalysis